Ranbaxy Pay-For-Delay Trial Kicks Off In Pa. Court
By Matt Fair ( June 14, 2017, 8:21 PM EDT) -- A Pennsylvania federal jury on Wednesday heard opening arguments in a closely watched pay-for-delay suit accusing drugmaker Ranbaxy of violating antitrust laws by accepting a settlement with rival Cephalon that improperly delayed generic forms of the narcolepsy medication Provigil from the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.